Antimicrobial resistance (AMR)
3 European H2020 organizations list this as part of their work.
Most active in this area
- STATENS SERUM INSTITUT
Denmark's national infectious disease institute, specializing in vaccine development, epidemic surveillance, and antimicrobial resistance research across European consortia.
“Contributed to CARTNET (AMR training network), COMBINE (MDR bacterial infections), and FAIR (adjunct therapy for drug-resistant pneumonia).”
DK22 projects - LIONEX GMBH
German biotech SME providing TB antigens, diagnostic reagents, and assay expertise for vaccine and infectious disease research consortia.
“BactiVax expanded scope beyond TB to ESKAPE organisms and antimicrobial resistant bacteria, signaling growing AMR capability.”
SMEDE3 projects - Centre hospitalier universitaire de Limoges
French university hospital running EU clinical trials in sepsis, cell therapy, infectious diseases, and antimicrobial resistance.
“AMR is a core ECRAID-Base research pillar, placing CHU Limoges in European AMR clinical trial networks.”
FR2 projects